Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients.

Molecular psychiatry - 1 May 2007

Ruaño G, Goethe J W, Caley C, Woolley S, Holford T R, Kocherla M, Windemuth A, de Leon J

Abstract excerpt

Atypical antipsychotics induce pre-diabetic symptoms in some but not all patients, characterized most notably by elevated weight. The side effect profiles of the various drugs in the class differ, however, raising the possibility of drug-specific mechanisms for similar side effects. We used physiogenomic analysis, an approach previously employed to study the genetics of drug and diet response, to discover and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoproteins
Share to Appetite Regulation
Share to Benzodiazepines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Olanzapine

Share to Receptors, Leptin

Share to Receptors, Neuropeptide Y

Share to Risperidone

Share to Scavenger Receptors, Class B

Source

Identifiers

PMID: 17199131
DOI: 10.1038/sj.mp.4001944

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients.PMID 17199131Read ↗

Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.Semantic proximity Read ↗

Pharmacogenetics of Leptin in Antipsychotic-Associated Weight Gain and Obesity-Related ComplicationsSemantic proximity Read ↗

Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.Semantic proximity Read ↗

A meta-analysis of potential genetic factors associated with antipsychotic-induced weight gain in adults with severe mental illness.Semantic proximity Read ↗

Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed.Semantic proximity Read ↗

Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysisSemantic proximity Read ↗

Genetic Correlates of Olanzapine-Induced Weight Gain in Schizophrenia Subjects from North India: Role of Metabolic Pathway GenesSemantic proximity Read ↗

Pharmacogenetics of antipsychotics: recent progress and methodological issuesSemantic proximity Read ↗

Pharmacogenetic Aspects of Antipsychotic Drug-induced Weight Gain - A Critical ReviewSemantic proximity Read ↗

Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic DrugsSemantic proximity Read ↗

Genetics of antipsychotic treatment emergent weight gain in schizophrenia.Semantic proximity Read ↗

Genetics of second-generation antipsychotic and mood stabilizer-induced weight gain in bipolar disorder: common and specific effects of key regulators of fat-mass homoeostasis genes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.